Nomura Holdings Inc. Acquires 38,659 Shares of Colgate-Palmolive Company $CL

Nomura Holdings Inc. grew its holdings in shares of Colgate-Palmolive Company (NYSE:CLFree Report) by 150.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 64,272 shares of the company’s stock after acquiring an additional 38,659 shares during the period. Nomura Holdings Inc.’s holdings in Colgate-Palmolive were worth $5,842,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC grew its stake in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares during the period. Fox Run Management L.L.C. bought a new position in shares of Colgate-Palmolive in the first quarter worth approximately $321,000. Brandywine Global Investment Management LLC purchased a new stake in shares of Colgate-Palmolive in the first quarter worth $5,431,000. EverSource Wealth Advisors LLC raised its position in shares of Colgate-Palmolive by 13.9% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,541 shares of the company’s stock valued at $519,000 after purchasing an additional 675 shares during the period. Finally, American Century Companies Inc. lifted its stake in shares of Colgate-Palmolive by 12.1% during the 1st quarter. American Century Companies Inc. now owns 915,313 shares of the company’s stock valued at $85,765,000 after buying an additional 98,605 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have commented on CL. JPMorgan Chase & Co. decreased their price target on Colgate-Palmolive from $88.00 to $87.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $80.00 to $77.00 and set an “underweight” rating on the stock in a report on Monday, November 3rd. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a report on Friday, October 3rd. They set a “neutral” rating and a $84.00 price objective for the company. Royal Bank Of Canada upgraded shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective on the stock in a research report on Tuesday, December 9th. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. Ten analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $89.00.

View Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $79.44 on Tuesday. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $100.18. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The firm’s fifty day moving average is $78.28 and its 200 day moving average is $83.38. The company has a market cap of $64.03 billion, a price-to-earnings ratio of 22.25, a PEG ratio of 5.58 and a beta of 0.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 EPS. Sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.